Protocol for a scoping review of multi-omic analysis for rare diseases.
Katie KerrHelen McAneneyAmy Jayne McKnightPublished in: BMJ open (2019)
As a secondary analysis study with no primary data generated, this scoping review does not require ethical approval. We anticipate this review will highlight a gap in rare disease research and provide direction for novel research. The completed review will be submitted for publication in peer-reviewed journals and presented at relevant conferences discussing rare disease research and/or molecular strategies.